The Airway Epithelium-A Central Player in Asthma Pathogenesis

Area of Science:

• Pulmonary Medicine
• Immunology
• Cell Biology

Background:

• Asthma is a chronic airway inflammatory disease with variable airflow obstruction.
• The airway epithelium acts as a primary defense barrier, crucial for host defense and immune regulation.
• Epithelial barrier dysfunction is increasingly recognized as a key feature of asthma pathology.

Purpose of the Study:

• To review the biology of the airway epithelium in healthy individuals and its pathobiology in asthma.
• To discuss the impact of external triggers like allergens, viruses, and alarmins on airway epithelial function in asthma.
• To explore epigenetic mechanisms and the airway epithelium's potential as a therapeutic target for asthma.

Main Methods:

• Literature review focusing on airway epithelial biology and asthma.
• Analysis of the role of external triggers (allergens, viruses, alarmins) and type 2 inflammation.
• Examination of epigenetic regulation and gene expression in airway epithelium.

Main Results:

• Asthma is characterized by impaired airway epithelial barrier function, facilitating allergen and pathogen entry.
• Susceptibility genes for asthma are often expressed in the airway epithelium.
• Type 2 inflammation significantly affects airway epithelial function in asthma.

Conclusions:

• The airway epithelium plays a critical role in asthma pathogenesis.
• Dysfunctional epithelial barrier and altered gene expression contribute to asthma.
• Targeting the airway epithelium presents a promising avenue for novel asthma therapies.